0001020859-26-000006
SEC filingUnited Natural Foods, Inc. (UNFI) reported Q2 2026 net sales of $7.95 billion, generating gross profit of $1.05 billion and net income attributable to the company of $20 million. Operating income was $57 million, impacted by $8 million in restructuring, acquisition and integration expenses and a $9 million loss on asset sales. The company generated $245 million in net cash from operating activities, with free cash flow of $189 million after $56 million in capital expenditures. Key balance sheet items include total assets of $7.25 billion, total liabilities of $5.69 billion, and stockholders' equity of $1.55 billion. The company ended the quarter with $52 million in cash and cash equivalents, with total debt of $1.71 billion in long-term debt plus $7 million in current portion. No prior period comparisons are provided in the XBRL data or document text for QoQ analysis.
United Natural Foods, Inc. reported Q2 2026 financial results with net sales of $7.95 billion and cost of sales of $6.90 billion, resulting in gross profit of $1.05 billion. Operating expenses totaled $972 million, with additional restructuring, acquisition and integration related expenses of $8 million and a loss on sale of assets and other asset charges of -$9 million. This yielded operating income of $57 million. After interest expense of $32 million and other adjustments, income before taxes was $23 million. With a $3 million provision for income taxes, net income including noncontrolling interests was $20 million, all attributable to United Natural Foods, Inc. No prior period QoQ comparisons are provided in the XBRL data or document text.
No segment breakdown, geographic mix, or growth drivers are disclosed in the provided XBRL data or document text. The company reported net sales of $7.95 billion for the quarter ending January 31, 2026, but no further revenue analysis information is available in the source materials.
The company achieved a gross margin of 13.2% ($1.05 billion gross profit on $7.95 billion net sales). Operating margin was 0.7% ($57 million operating income on $7.95 billion net sales). Operating expenses of $972 million represented 12.2% of net sales. The cost structure shows cost of sales of $6.90 billion, representing 86.8% of net sales. No prior period margin comparisons are provided in the XBRL data or document text.
The company generated $245 million in net cash from operating activities, with key adjustments including $74 million in depreciation and amortization and $27 million in share-based compensation. Investing activities used $46 million, primarily for $56 million in capital expenditures, resulting in free cash flow of $189 million. Financing activities used $192 million, mainly from net repayments under the revolving credit line. The balance sheet shows total assets of $7.25 billion, including $3.25 billion in current assets with $1.99 billion in inventories. Total liabilities are $5.69 billion, including $1.71 billion in long-term debt. Stockholders' equity is $1.55 billion, resulting in a debt-to-equity ratio of approximately 1.1:1.
No management guidance, strategic priorities, or specific risk factors are disclosed in the provided XBRL data or document text. The filing contains standard financial statements without forward-looking statements or outlook commentary in the extracted content.